Doctor profile · Federal record
Dr. Stuart Garay, MD
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Internal Medicine Physician · New York, NY
- NPI 1841392826
- Accepts Medicare
- MIPS 84.5 / 100 · 2023
- 52 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
436 3Rd Ave
New York, NY 100166025
(212) 685-6660
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- June 10, 2021
- Year of graduation
- 1974 — 52 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- New York #126329
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841392826. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,294
Distinct HCPCS
9
Medicare allowed
$172,107
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 1,107 | 262 | $0 | |
94726 |
Test to determine lung volumes using sensors | 498 | 307 | $64 | |
94729 |
Test to examine how well the lungs exchange gases | 493 | 306 | $67 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 465 | 290 | $46 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 368 | 268 | $104 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 295 | 198 | $147 | |
94010 |
Test to measure expiratory airflow and volume | 34 | 31 | $32 | |
J7612 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | 20 | 19 | $0 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 14 | 14 | $193 |
In context: peer comparison
Among 108 peers in this city , average services per provider: 150. This provider delivers 22× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
1,504
Patients
389
Total drug cost
$627,877
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 310 | 56 | $165,896 |
| Montelukast Sodium | Generic | 235 | 63 | $3,591 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 165 | 40 | $92,420 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 131 | 64 | $5,046 |
| Incruse Ellipta (Umeclidinium Bromide) | Brand | 110 | 22 | $61,403 |
| Arnuity Ellipta (Fluticasone Furoate) | Brand | 99 | 24 | $39,233 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 90 | 17 | $94,697 |
| Flovent Hfa (Fluticasone Propionate) | Brand | 77 | 18 | $35,104 |
| Advair Diskus (Fluticasone Propion/Salmeterol) | Brand | 62 | 13 | $43,499 |
| Spiriva Handihaler (Tiotropium Bromide) | Brand | 54 | 15 | $47,671 |
Hospital affiliations
Frequently asked questions
What is Dr. Stuart Garay's medical specialty?
Dr. Stuart Garay practices Pulmonary Disease Physician in New York, NY.
Where does Dr. Stuart Garay practice?
Dr. Stuart Garay practices at 436 3Rd Ave, New York, NY 100166025. Office phone: 2126856660.
What is Dr. Stuart Garay's NPI?
Dr. Stuart Garay's National Provider Identifier (NPI) is 1841392826, issued by NPPES.
Does Dr. Stuart Garay accept Medicare assignment?
Yes. Dr. Stuart Garay accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stuart Garay commonly perform?
Top Medicare-reported procedures in 2023: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS J7613); Test to determine lung volumes using sensors (HCPCS 94726); Test to examine how well the lungs exchange gases (HCPCS 94729). Source: CMS Medicare Physician & Other Practitioners file.